Patent Assignment
Reel/Frame 052892/0702
Assignment of Assignor's Interest
Recorded: 2020-06-10
Pages: 13
Assignor
TAMIR BIOTECHNOLOGY, INC.
Executed: 2020-04-17
Assignee
ORGENESIS INC.
20271 GOLDENROD LANE, GERMANTOWN, MARYLAND, 20876
Covered Properties
(25)
Prophylactic Protection Against Viral Infections, Particularly Hiv
Methods and Pharmaceuticals for Treatment of Viral Infections of the Eye
Application:
16/368,330 →
Publication:
US 2019/0216904
Prophylactic Protection Against Viral Infections, Particularly Hiv
Application:
62/367,050 →
Prophylactic Protection Against Viral Infections
Compositions and Methods Using Ranpirnase and Quinine Derivatives
Application:
62/992,408 →
Inhibitors of Angiotensin Converting Enzyme (Ace-I) Associated with Rnase as Treatment of Coronavirus Infection
Application:
63/005,582 →
Ribonucleases and Methods of Making Them Recombinantly
Fusion Protein Incorporating a Cysteinized Ribonuclease
Cysteinized Ribonuclease and Targeting Moiety Conjugated Thereto
Cysteinized Ribonuclease and Targeting Moiety Conjugated Thereto
Nucleic Acid Encoding a Novel Ribonuclease Having an Amino Acid Sequence Made Up of the Amino Acid Sequence of a Known Ribonuclease and an N-Terminal Leader Sequence That Is at Least One Residue Long
Nucleic Acid Encoding a Novel Ribonuclease Having an Amino Acid Sequence Made Up of the Amino Acid Sequence of a Known Ribonuclease and an N-Terminal Leader Sequence That Is at Least One Residue Long
Nucleic Acid Encoding a Novel Ribonuclease Having an Amino Acid Sequence Made Up of a Known Amino Acid Sequence and an Initial N-Terminal Residue
Nucleic Acid Encoding Cysteinized Ribonuclease to Which a Targeting Moiety Can Be Conjugated
Nucleic Acid Encoding a Fusion Protein Incorporating a Cysteinized Ribonuclease
Nucleic Acid Encoding a Novel Ribonuclease Having an Amino Acid Sequence Made Up of the Amino Acid Sequence of a Known Ribonuclease and an N-Terminal Leader Sequence
Methods of Treating Infections Originating from Viruses in the Herpesviridae Family
Methods of Treating Infections Originating from Viruses in the Herpesviridae Family
Methods of Treating Human Papillomavirus
Methods of Treating and Prophylactically Protecting Mammalian Patients Infected by Viruses Classified in Baltimore Group V
Antiviral Pharmaceutical for Topical Administration
Methods and Pharmaceuticals for Treatment of Viral Infections of the Eye
Rnase for Use in Treating Viral Infections
PCT:
PCT/US2015/022670 ↗
Pharmaceutical Composition Containing an Rnase
PCT:
PCT/US2015/045272 ↗
Pharmaceuticals for Treatment of Viral Infections of the Eye
PCT:
PCT/US2016/037174 ↗
Related Assignments
(17)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Mar 1, 2004
From: SAXENA, SHAILENDRA K.
To: ALFACELL CORPORATION
Reel/Frame 014385/0201 →
Assignment of Assignor's Interest
Nov 17, 2010
From: SAXENA, SHAILENDRA K., DR.; ARDELT, WOJCIECH, DR.
To: TAMIR BIOTECHNOLOGY, INC.
Reel/Frame 025383/0476 →
Assignment of Assignor's Interest
Jul 20, 2011
From: SAXENA, SHAILENDRA K., PH.D
To: TAMIR BIOTECHNOLOGY, INC.
Reel/Frame 026617/0755 →
Assignment of Assignor's Interest
Jul 20, 2011
From: ARDELT, WOJCIECH, PH.D
To: TAMIR BIOTECHNOLOGY, INC.
Reel/Frame 026617/0809 →
Assignment of Assignor's Interest
Aug 4, 2016
From: SQUIQUERA, LUIS, DR.
To: TAMIR BIOTECHNOLOGY, INC.
Reel/Frame 039342/0235 →
Assignment of Assignor's Interest
Sep 20, 2019
From: SQUIQUERA, LUIS
To: TAMIR BIOTECHNOLOGY, INC.
Reel/Frame 050445/0234 →
Assignment of Assignor's Interest
Sep 20, 2019
From: SULLEY, JAMIE
To: TAMIR BIOTECHNOLOGY, INC.
Reel/Frame 050445/0255 →
Assignment of Assignor's Interest
Mar 27, 2020
From: SAXENA, SHAILENDRA K.
To: ALFACELL CORPORATION
Reel/Frame 052241/0958 →
Change of Name
Mar 27, 2020
From: ALFACELL CORPORATION
To: TAMIR BIOTECHNOLOGY, INC.
Reel/Frame 052251/0288 →
Assignment of Assignor's Interest
Mar 27, 2020
From: SAXENA, SHAILENDRA K., DR.; ARDELT, WOJCIECH, DR.
To: TAMIR BIOTECHNOLOGY, INC.
Reel/Frame 052243/0031 →
Assignment of Assignor's Interest
Mar 27, 2020
From: SQUIQUERA, LUIS; HODGE, THOMAS; SULLEY, JAMIE
To: TAMIR BIOTECHNOLOGY, INC.
Reel/Frame 052244/0715 →
Assignment of Assignor's Interest
Mar 27, 2020
From: SULLEY, JAMIE; SQUIQUERA, LUIS; HODGE, TOM
To: TAMIR BIOTECHNOLOGY, INC.
Reel/Frame 052244/0727 →
Assignment of Assignor's Interest
Mar 30, 2020
From: SULLEY, JAMIE; SQUIQUERA, LUIS; SIDRANSKY, DAVID; HODGE, TOM
To: TAMIR BIOTECHNOLOGY, INC.
Reel/Frame 052256/0582 →
Assignment of Assignor's Interest
Apr 6, 2020
From: SULLEY, JAMIE; SQUIQUERA, LUIS
To: TAMIR BIOTECHNOLOGY, INC.
Reel/Frame 052322/0322 →
Final Judgment, Writ of Execution and Judgment Lien Certificate
Aug 20, 2025
From: ORGENESIS INC.
To: BACAL, MURRAY
Reel/Frame 072485/0057 →
Assignment of Assignor's Interest
Feb 25, 2026
From: ORGENESIS INC.
To: OKOGEN, INC.
Reel/Frame 073890/0884 →
Assignment of Assignor's Interest
Mar 12, 2026
From: ORGENESIS, INC
To: OKOGEN, INC
Reel/Frame 074059/0717 →